Eli Lilly | LLY - Market Capitalization


Eli Lilly reported $1.07T in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Abbott USD 158.05B 20.36B Jun/2026
ALKERMES USD 7.93B 806M Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Baxter International USD 11.01B 2.34B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 324.18B 6.81B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 143.89B 5.44B Aug/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026